The Incidence, Risk Factors, and Outcomes of Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplant Recipients
DOI:
https://doi.org/10.52547/3jdey681Abstract
Introduction. Acute kidney injury (AKI) is a frequent complication after hematopoietic stem cell transplantation (HSCT), with reported incidences ranging from 20-70% within the first 100 days post-transplant. AKI can adversely impact outcomes and survival in this patient population.
Methods. This retrospective study evaluated 110 pediatric patients who underwent HSCT at Mofid Children’s Hospital, affiliated with Shahid Beheshti University of Medical Sciences, Tehran, Iran, between 2016-2021. AKI was defined and staged according to the criteria for Kidney Disease Improving Global Outcomes (KDIGO). Results. The cohort comprised 68 (61.8%) males and 42 (38.2%) females, with a mean age of 6.4 ± 4.1 years. Underlying disorders were malignant in 64 (58.1%) and non-malignant in 46 (41.9%) patients. Among the cohort, 84 (76.3%) patients underwent allogeneic HSCT, while 26 (23.7%) received autologous HSCT. Myeloablative and reduced-intensity conditioning regimens were used in 77 (70%) and 33 (30%) patients, respectively. AKI developed in 53 (48%) patients within 100 days post-transplant, with incidences of 38%, 40%, and 22% for stages 1, 2, and 3 AKI, respectively. AKI incidence was higher in allogeneic HSCT (52%) compared to autologous HSCT (17%; P = 0.023). Younger age (P = 0.033) and non-malignant disorders (P = 0.033) were associated with increased AKI risk. At the end of the study, 77 (70%) patients were alive, and 33 (30%) had deceased, with a significant positive correlation between AKI stage and mortality (P = 0.004).
Conclusion. This study highlights the high prevalence of AKI among pediatric HSCT recipients, particularly those undergoing allogeneic HSCT, at a younger age, and with non-malignant disorders. Regular post-transplant renal monitoring may improve survival in this population.
Downloads
References
1. D’Souza, A., et al., Current use and trends inhematopoietic cell transplantation in the United States,2017, Elsevier. p. 1417-1421.
2. Shamsian, B.S., et al., Allogenic hematopoietic stem cell transplantation in an Iranian patient with osteopetrosis caused by carbonic anhydrase II deficiency: A case report.Pediatric Transplantation, 2024. 28(3): p. e14689.
3. Koh, K.-N., et al., Acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation:incidence, risk factors, and outcomes. Biology of Blood and Marrow Transplantation, 2018. 24(4): p. 758-764.
4. Didsbury, M.S., F.E. Mackie, and S.E. Kennedy, A systematic review of acute kidney injury in pediatricallogeneic hematopoietic stem cell recipients. Pediatric transplantation, 2015. 19(5): p. 460-470.
5. Lopes, J. and S. Jorge, Acute kidney injury following HCT: incidence, risk factors and outcome. Bone marrow transplantation, 2011. 46(11): p. 1399-1408.
6. Hahn, T., et al., Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone marrow transplantation, 2003. 32(4): p. 405-410.
7. Wanchoo, R., et al., Acute kidney injury in hematopoietic stem cell transplantation. Current Opinion in Critical Care, 2019. 25(6): p. 531-538.
8. Parikh, C.R., et al., Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney international, 2002. 62(2): p. 566-573.
9. Kogon, A. and S. Hingorani. Acute kidney injury in hematopoietic cell transplantation. in Seminars in nephrology. 2010. Elsevier.
10. Sawinski, D., The kidney effects of hematopoietic stem cell transplantation. Advances in chronic kidney disease, 2014. 21(1): p. 96-105.
11. Rondón, G., et al., Impact of fluid overload as new toxicity category on hematopoietic stem cell transplantation outcomes. Biology of Blood and Marrow Transplantation, 2017. 23(12): p. 2166-2171.
12. Parikh, C.R., et al., Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. American Journal of Kidney Diseases,2005. 45(3): p. 502-509.
13. Hingorani, S.R., et al., Acute renal failure aftermyeloablative hematopoietic cell transplant: incidence and risk factors. Kidney international, 2005. 67(1): p. 272-277.
14. Kersting, S., et al., Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone marrow transplantation, 2007. 39(6): p. 359-365.
15. Kist-van Holthe, J.E., et al., Prospective study of renal insufficiency after bone marrow transplantation. Pediatric Nephrology, 2002. 17(12): p. 1032-1037.
16. Kizilbash, S.J., et al., Acute kidney injury and the risk of mortality in children undergoing hematopoietic stemcell transplantation. Biology of Blood and Marrow Transplantation, 2016. 22(7): p. 1264-1270.
17. Andronesi, A., et al., Incidence and risk factors for acute kidney injury after allogeneic stem cell transplantation: a prospective study. Biomedicines, 2022. 10(2): p. 262.
18. Ando, M., et al., A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after
hematopoietic SCT. Bone marrow transplantation, 2010. 45(9): p. 1427-1434.
19. Khwaja, A., KDIGO clinical practice guidelines for acute kidney injury. Nephron Clinical Practice, 2012. 120(4): p.c179-c184.
20. Akcan-Arikan, A., et al., Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney international, 2007. 71(10): p. 1028-1035.
21. Schwartz, G.J. and D.F. Work, Measurement and estimation of GFR in children and adolescents. Clinical Journal of the American Society of Nephrology, 2009. 4(11): p. 1832-1843.
22. Avcı, B., et al., Acute kidney injury and risk factors in pediatric patients undergoing hematopoietic stem cell transplantation. Pediatric Nephrology, 2024: p. 1-9.
23. Hirano, D., et al., Independent risk factors and long-termoutcomes for acute kidney injury in pediatric patients undergoing hematopoietic stem cell transplantation: aretrospective cohort study. BMC nephrology, 2020. 21: p. 1-7.
24. Ileri, T., et al., Prospective evaluation of acute and chronic renal function in children following matched related donor hematopoietic stem cell transplantation. Pediatric transplantation, 2010. 14(1): p. 138-144.
25. Rajpal, J.S., et al., Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 2013. 19(4): p. 661-665.
26. Bagshaw, S.M., et al., Urinary biomarkers in septic acute kidney injury. Intensive care medicine, 2007. 33(7): p.1285-1296.
